Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial

The purpose of this study was to evaluate the long-term effectiveness and safety of blonanserin, a second-generation antipsychotic drug developed in Japan, in patients with first-episode schizophrenia. Twenty-three antipsychotic-naïve patients with first-episode schizophrenia were treated within an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Psychiatry and clinical neurosciences 2014-12, Vol.68 (12), p.841-849
Hauptverfasser:	Ninomiya, Yuriko, Miyamoto, Seiya, Tenjin, Tomomi, Ogino, Shin, Miyake, Nobumi, Kaneda, Yasuhiro, Sumiyoshi, Tomiki, Yamaguchi, Noboru
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - pharmacology Female Follow-Up Studies Humans Male Piperazines - administration & dosage Piperazines - adverse effects Piperazines - pharmacology Piperidines - administration & dosage Piperidines - adverse effects Piperidines - pharmacology Quality of Life Schizophrenia - drug therapy Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!